No Data
Day One Biopharmaceuticals Announces Leadership Transition
Express News | Day One Announces Retirement of DR. Samuel Blackman, Co-Founder and Head of Research & Development
JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas
Day One Biopharmaceuticals Insider Sold Shares Worth $456,223, According to a Recent SEC Filing
Express News | Day One Biopharmaceuticals Inc : JP Morgan Raises Target Price to $39 From $36
J.P. Morgan Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating